Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesA phase I/II study of gti-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: a study of the PMH Phase II Consortium
Journal of Thoracic Oncology, 09/02/09
Leighl NB et al. – The combination of GTI-2040 (an antisense oligonucleotide) + docetaxel is not superior to docetaxel alone in previously treated NSCLC.
Methods- 29 patients with advanced solid tumors, PS 0-2, no symptomatic CNS metastases, adequate organ and BM function, and ≥ 1 prior chemotherapy regimen were treated with escalating doses of GTI-2040 + docetaxel
- GTI-2040 + docetaxel was not superior to docetaxel alone in the treatment of previously treated NSCLC
Related Articles
Molecular Characterization of Chronic Obstructive Pulmonary Disease-Related Non-Small Cell Lung Cancer Through Aberrant Methylation and Alterations of EGFR Signaling
Annals of Surgical Oncology, 10/23/09
Relevance Score: 89%
Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer
Annals of Oncology, 10/19/09
Relevance Score: 87%
Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: An analysis of RTOG 9801
Journal of Clinical Oncology, 10/29/09
Relevance Score: 85%
Expression and Significance of Clusterin in Anip973/CDDP Cell Lines
Chinese Journal of Lung Cancer, 10/23/09
Relevance Score: 85%
Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer
British Journal of Cancer, 10/19/09
Relevance Score: 85%
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Paraneoplastic syndromes in patients with oral cancer
Oral Oncology , 11/25/09
Early radiation-induced laryngeal malignant fibrous histiocytoma (MFH)
Clinical and Translational Oncology, 11/25/09
Prognostic value of a three-grade classification in primary epithelial parotid carcinoma: Result of a histological review from a 20-year experience of total parotidectomy with neck dissection in a single institution
European Journal of Cancer, 11/25/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy
Oncogene, 11/25/09
Fhit regulates invasion of lung tumor cells
Oncogene, 11/25/09
Choroidal metastases from lung adenocarcinoma
Clinical and Translational Oncology, 11/25/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
Oncogene, 11/25/09
Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors
Investigational New Drugs, 11/25/09
Adding more content to screening: reactivation of FOXO as a therapeutic strategy
Clinical and Translational Oncology, 11/25/09
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis
Oncogene, 11/25/09
Extrapulmonary small cell carcinoma in breast and prostate
Clinical and Translational Oncology, 11/25/09
Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients
Cancer, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor